Professor Anna Goodman is an Infectious Diseases specialist and Clinical Trials physician. Her key research interests are pragmatic clinical trials in bacterial infections, and she is the UK chief investigator of the SNAP trial, which explores optimal diagnosis and treatment of S. aureus bacteraemia. She works at KCL and she also holds a clinical position as a Consultant in Infectious Diseases at Guy’s and St Thomas’ NHS Foundation Trust in London.

She completed her DPhil as an MRC Clinical Research Training Fellow in Oxford on viral vectored vaccines against malaria, leading from bench to bedside. Her academic and clinical research focuses on pragmatic clinical trials in infectious diseases. Such pragmatic trials range from vaccine and treatment trials in COVID-19 to trials to trials in bloodstream infection, such as S. aureus bacteraemia. She has associated interests in imaging in infection, malaria, non-tuberculous mycobacteria and bloodstream infection due to bacteria or fungi. Her particular interest is in platform trials.

In addition to being national CI on SNAP, and local PI on >10 trials with recruitment >1000 participants she has been working on infection-related clinical trial management teams and end-point review committees including in the fields of HIV and community-acquired pneumonia. She is currently international co-chair of the scientific subcommittee of Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE).

Professor Anna Goodman's ORCID account